loader2
Login Open ICICI 3-in-1 Account

Inventurus Knowledge Solutions Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Inventurus Knowledge Solutions Ltd. 31 Oct 2025 11:20 AM

Q2FY26 Quarterly Result Announced for Inventurus Knowledge Solutions Ltd.

Healthcare Services company Inventurus Knowledge Solutions announced Q2FY26 results

  • Revenue: Rs 7,811 million compared to Rs 6,428 million during Q2FY25, change 22%.
  • EBITDA: Rs 2,718 million compared to Rs 1,898 million during Q2FY25, change 43%.
  • PAT: Rs 1,807 million compared to Rs 1,130 million during Q2FY25, change 60%.

Sachin K. Gupta, Founder & Global CEO, IKS Health, said: “The second quarter was a period of significant strategic execution and strong financial performance for IKS Health. Our results underscore the growing market demand for our Care Enablement Platform as health systems increasingly recognize the need to holistically address administrative, clinical, and financial challenges.”

“A key highlight of this quarter was the launch of our Agentic AI platform on Google Cloud and native integration of Scribble Now, our ambient AI scribing solution, into revenue cycle management, coding, and clinical documentation workflows, creating the industry’s first connected encounter-to-reimbursement platform and winning the 2025 Dora Award from Google Cloud Award for ‘Augmenting Human Expertise with AI’. We have also significantly accelerated the execution of our AI strategy, marked by the appointment of our new Chief AI Officer. These accomplishments reflect our unwavering commitment to augmenting human expertise to deliver unparalleled clinical, financial, and operational excellence to our clients."

Nithya Balasubramanian, Group CFO, IKS Health said: “IKS Health’s strong Q2FY26 financial performance, highlighted by a 22% YoY Revenue, 43% EBITDA and 60% PAT growth reflects our continued focus on driving consistent, profitable growth. The improvement in our EBITDA margin showcases the scalability of our platform and disciplined capital management. As we progress, we will maintain this balanced approach—preserving margin strength while investing strategically to support sustainable growth and long-term shareholder value.”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q1FY26 results

  • Revenue at Rs 7,401 million (15.6% YoY / 2.2% QoQ growth).
  • EBITDA at Rs 2,378 million at 32.1% of revenue (36.3% YoY / 5.1% QoQ growth).
  • PAT at Rs 1,515 million at 20.5% of revenue (58.7% YoY / 2.5% QoQ growth)
  • Adjusted PAT at Rs 1,682 million at 22.7% of revenue (51.4% YoY / 2.2% QoQ growth).

Sachin K. Gupta, Founder & Global CEO, IKS Health, said: “Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution.”

“The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities. As we move forward, our focus remains on deepening client value, investing in innovation, and scaling our platform to address the evolving needs of the healthcare ecosystem.”

Nithya Balasubramanian, CFO, IKS Health said: “We delivered a strong financial performance in Q1FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation.”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Revenue growth in Q4, 17% YoY in INR, 13% YoY in USD
  • Q4 EBITDA up 68% YoY; 13% QoQ
  • PAT up 133% growth YoY; 14% QoQ
  • Adjusted PAT up 108% YoY; 13% QoQ
  • Revenue:  7,240 million
  • PAT: Rs 1,478 million
  • EBITDA: Rs 2,262 million
  • Adjusted PAT: Rs 1,646 million

FY25 Financial Highlights:

  • Revenue at Rs 26,640 million (47% YoY)
  • EBITDA at Rs 7,911 million (50% YoY)
  • PAT at Rs 4,861 million (31% YoY) 
  • Adjusted PAT at Rs 5,504 (39% YoY)

Sachin K. Gupta, Founder & CEO, IKS Health. said, “The results for the quarter reflect the strength of our business where we have delivered industry leading revenue growth owing to ramp up of new clients and continuous margin improvement as we continue to transform the business using technology and global human capital. Our Q4FY25 EBITDA margins have crossed 31%, a significant improvement from the 24% proforma margin of FY24,”

 “The last quarter saw five prominent client wins including three platform deals which gives us the confidence in our strategy of building the full breadth of our platform in a market that largely consists of point solutions companies.”

Nithya Balasubramanian, CFO, IKS Health said, “We have delivered a very healthy margin and strong revenue growth of 17% YoY and 10% QoQ despite some compression in revenue as we focus on the right set of customers and globalize the legacy AQuity workforce. Ongoing investments in technology and AI will remain central to our strategy for achieving excellence in outcomes and client satisfaction.”

Result PDF

Healthcare Services company Inventurus Knowledge Solutions announced Q3FY25 results

  • Revenue at Rs 6,572 million (15.9% YoY / 2.2% QoQ growth).
  • EBITDA at Rs 2,006 million at 30.5% of revenue (24.3% YoY / 5.7% QoQ growth).
  • PAT at Rs 1,297 million at 19.7% of revenue (27.7% YoY / 14.8% QoQ growth).
  • Adjusted PAT at Rs 1,455 million at 22.1% of revenue (30.6% YoY / 12.8% QoQ growth).

Sachin K. Gupta, Founder and Chief Executive Officer, IKS Health, said: “We continue our journey of improving profitability by transforming legacy AQuity’s operating model through technology and global human capital. EBITDA margins have crossed 30% this quarter, a significant improvement from the 24% proforma margin of FY24. With revenue from our top five customers growing 19% and new client acquisitions ramping up, we are optimistic about sustained growth heading into the final quarter and the next financial year.”

Nithya Balasubramanian, Chief Financial Officer, IKS Health, said: “We are steadily regaining our legacy IKS EBITDA margins. PAT growth has outpaced EBITDA growth due to lower finance costs as we continue to repay our debt. Adjusted PAT, excluding non-cash amortization of acquired intangibles, has improved by 31%. We will maintain our investments in technology and AI to drive superior outcomes and enhance customer satisfaction.”

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app